SG11201504744WA - 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease - Google Patents
4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal diseaseInfo
- Publication number
- SG11201504744WA SG11201504744WA SG11201504744WA SG11201504744WA SG11201504744WA SG 11201504744W A SG11201504744W A SG 11201504744WA SG 11201504744W A SG11201504744W A SG 11201504744WA SG 11201504744W A SG11201504744W A SG 11201504744WA SG 11201504744W A SG11201504744W A SG 11201504744WA
- Authority
- SG
- Singapore
- Prior art keywords
- enecarbaldehyde
- cyclohex
- ylidene
- propan
- neurodegenerative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/46—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU92126A LU92126B1 (en) | 2012-12-31 | 2012-12-31 | Pharmaceutical compound for the prevention and treatment of a disorder or disease of memory, neurodegenerative or neuronal |
| PCT/EP2013/076936 WO2014102090A1 (en) | 2012-12-31 | 2013-12-17 | 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504744WA true SG11201504744WA (en) | 2015-07-30 |
Family
ID=47470067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504744WA SG11201504744WA (en) | 2012-12-31 | 2013-12-17 | 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US9284250B2 (en) |
| EP (1) | EP2938337A1 (en) |
| JP (1) | JP6699961B2 (en) |
| KR (1) | KR102104155B1 (en) |
| CN (1) | CN104884052B (en) |
| AR (1) | AR094318A1 (en) |
| AU (1) | AU2013369491B2 (en) |
| BR (1) | BR112015015509B1 (en) |
| CA (1) | CA2895429C (en) |
| CL (1) | CL2015001881A1 (en) |
| EA (1) | EA029650B1 (en) |
| HK (1) | HK1214517A1 (en) |
| IL (1) | IL239622B (en) |
| JO (1) | JO3483B1 (en) |
| LU (1) | LU92126B1 (en) |
| MA (1) | MA38307B1 (en) |
| MX (1) | MX369590B (en) |
| MY (1) | MY171832A (en) |
| NZ (1) | NZ710131A (en) |
| PE (1) | PE20151424A1 (en) |
| PH (1) | PH12015501402B1 (en) |
| SG (1) | SG11201504744WA (en) |
| TN (1) | TN2015000275A1 (en) |
| TW (1) | TWI590819B (en) |
| UA (1) | UA117822C2 (en) |
| UY (1) | UY35253A (en) |
| WO (1) | WO2014102090A1 (en) |
| ZA (1) | ZA201505057B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS61767B1 (en) | 2012-12-21 | 2021-05-31 | Janssen Biopharma Inc | 4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv |
| US11434468B2 (en) * | 2017-01-13 | 2022-09-06 | Bened Biomedical Co., Ltd. | Lactic acid bacteria and its applications |
| KR102017415B1 (en) * | 2018-02-13 | 2019-09-02 | 연세대학교 산학협력단 | Composition for alleviate neural injury of brain |
| CN108813453A (en) * | 2018-05-23 | 2018-11-16 | 青岛大学 | A kind of edible composition for preventing and treating Parkinson's disease |
| CN114340415B (en) | 2019-12-02 | 2024-01-02 | 菲利普莫里斯生产公司 | Hookah device with groove |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068576A1 (en) * | 2000-03-10 | 2001-09-20 | Applied Genetics Incorporated Dermatics | Dermatological compounds |
| CN1511520A (en) * | 2002-12-31 | 2004-07-14 | �й�ҽѧ��ѧԺҩ���о��� | Use of succinate derivative for biologically treating dementia |
| US20060241133A1 (en) * | 2003-03-14 | 2006-10-26 | Shearman Mark S | Electrically variable pneumatic structural element |
-
2012
- 2012-12-31 LU LU92126A patent/LU92126B1/en active
-
2013
- 2013-12-17 JP JP2015550024A patent/JP6699961B2/en active Active
- 2013-12-17 EA EA201591021A patent/EA029650B1/en unknown
- 2013-12-17 PE PE2015001180A patent/PE20151424A1/en unknown
- 2013-12-17 CN CN201380069044.3A patent/CN104884052B/en active Active
- 2013-12-17 EP EP13808014.8A patent/EP2938337A1/en active Pending
- 2013-12-17 KR KR1020157020805A patent/KR102104155B1/en active IP Right Grant
- 2013-12-17 MY MYPI2015702083A patent/MY171832A/en unknown
- 2013-12-17 WO PCT/EP2013/076936 patent/WO2014102090A1/en active Application Filing
- 2013-12-17 BR BR112015015509-0A patent/BR112015015509B1/en active IP Right Grant
- 2013-12-17 CA CA2895429A patent/CA2895429C/en active Active
- 2013-12-17 AU AU2013369491A patent/AU2013369491B2/en active Active
- 2013-12-17 US US14/758,343 patent/US9284250B2/en active Active
- 2013-12-17 MX MX2015008520A patent/MX369590B/en active IP Right Grant
- 2013-12-17 NZ NZ710131A patent/NZ710131A/en unknown
- 2013-12-17 UA UAA201507037A patent/UA117822C2/en unknown
- 2013-12-17 MA MA38307A patent/MA38307B1/en unknown
- 2013-12-17 SG SG11201504744WA patent/SG11201504744WA/en unknown
- 2013-12-27 AR ARP130105072A patent/AR094318A1/en not_active Application Discontinuation
- 2013-12-30 UY UY0001035253A patent/UY35253A/en not_active Application Discontinuation
- 2013-12-30 JO JOP/2013/0390A patent/JO3483B1/en active
- 2013-12-30 TW TW102148993A patent/TWI590819B/en active
-
2015
- 2015-06-16 TN TNP2015000275A patent/TN2015000275A1/en unknown
- 2015-06-18 PH PH12015501402A patent/PH12015501402B1/en unknown
- 2015-06-24 IL IL239622A patent/IL239622B/en active IP Right Grant
- 2015-06-30 CL CL2015001881A patent/CL2015001881A1/en unknown
- 2015-07-14 ZA ZA2015/05057A patent/ZA201505057B/en unknown
-
2016
- 2016-03-04 HK HK16102495.8A patent/HK1214517A1/en unknown
- 2016-03-14 US US15/069,118 patent/US9611205B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265774B (en) | Diagnosis, prevention and treatment of diseases of the joint | |
| IL239368A0 (en) | Ppar-sparing thiazolidiones and combinations for the treatment of neurodegenerative diseases | |
| HK1214553A1 (en) | Laquinimod and pridopidine for treating neurodegenerative disorders | |
| IL239278B (en) | A compound including pyridine or pyrimidine and a non-aryl-heterocyclic amine, a medicament and the compound for use in the prophylaxis or treatment of epilepsy or neurodegenerative disease | |
| IL253441A0 (en) | Drug for preventing and/or treating polycystic kidney disease | |
| EP2948188A4 (en) | Neuronal imaging and treatment | |
| IL285248A (en) | Compound for use as a medicament for preventing and/or treating aging-associated cognitive impairment | |
| SG11201405028UA (en) | Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia | |
| GB201219873D0 (en) | Diverticulitis treatment | |
| EP2867239A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes | |
| HK1214517A1 (en) | 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease 4--2--5-(-2-)-3- | |
| AP2015008338A0 (en) | Compounds for the treatment and prevention of retroviral infections | |
| HK1207593A1 (en) | Medicament for treating mental and behavioural disorders | |
| SG11201504933WA (en) | Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same | |
| EP2723339A4 (en) | Compounds for treating peripheral neuropathies and other neurodegenerative disorders | |
| HK1218882A1 (en) | Combination therapeutics and methods for the treatment of neurodegenerative and other diseases | |
| HK1205464A1 (en) | Preventing or treating periodontal disease | |
| IL237912A0 (en) | Dihydro-6-azaphenalene derivatives for the treatment of cns, oncological diseases and related disorders | |
| EP2903436A4 (en) | Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies | |
| WO2014056779A8 (en) | Drug for the prophylaxis and treatment of a neurodegenerative disease | |
| PT2872131T (en) | Oleacein for treating or preventing diseases resulting from atherosclerotic plaques | |
| EP2844265A4 (en) | Pomegranate oil for preventing and treating neurodegenerative diseases | |
| HK1210967A1 (en) | Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders | |
| GB201219696D0 (en) | Agents for the prevention and/or treatment of central nervous system damamge |